SCHEMBL4875742

SCHEMBL4875742

CC(C)OC(=O)Nc1cc(F)c(C=CCO)c(F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.43
HPGD P15428 2/20 0.42
ALOX15 P16050 1/20 0.42
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41
CYP2D6 P10635 1/20 0.41
RAB9A P51151 1/20 0.41
CASP3 P42574 1/20 0.36
HTT P42858 2/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 3/20 0.35
MEN1 O00255 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
KMT2A Q03164 1/20 0.34
MMP2 P08253 1/20 0.34
MMP9 P14780 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4875726 1.00 KDM4E (0.43) KDM4EHPGDALOX15CYP1A2CYP2C9
SCHEMBL4873394 0.83 KDM4E (0.44) KDM4EHPGDALOX15CYP1A2CYP2C9
SCHEMBL4879199 0.82 KDM4E (0.43) KDM4EHPGDALOX15CYP1A2CYP2C9
SCHEMBL4879206 0.82 KDM4E (0.43) KDM4EHPGDALOX15CYP1A2CYP2C9
SCHEMBL4882291 0.81 KDM4E (0.48) KDM4EHPGDALOX15CYP1A2CYP2C9
SCHEMBL5379512 0.81 HPGD (0.44) KDM4EHPGDALOX15CYP1A2CYP2C9
SCHEMBL4879337 0.79 KDM4E (0.35) KDM4EHPGDALOX15CYP1A2CYP2C9
SCHEMBL4879348 0.79 KDM4E (0.35) KDM4EHPGDALOX15CYP1A2CYP2C9
SCHEMBL14197131 0.76 KDM4E (0.43) KDM4EHPGDALOX15CYP1A2CYP2C9
SCHEMBL5379517 0.76 KDM4E (0.43) KDM4EHPGDALOX15CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090884-A1 ANTIMICROBIAL [3.1.0] BICYCLOHEXYLPHENYL- OXAZOLIDINONE DERIVATIVES AND ANALOGUES PFIZER INC 2008-04-17 US disclosed
US-7279494-B2 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues PFIZER INC. (US) 2007-10-09 US disclosed
US-20050192325-A1 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues RENSLO ADAM (US) 2005-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050192325-A1 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues OXA1L, CYP51A1, CYP2C19 KDM4E 3740/4885HPGD 473/4885ALOX15 2538/4885
US-20080090884-A1 ANTIMICROBIAL [3.1.0] BICYCLOHEXYLPHENYL- OXAZOLIDINONE DERIVATIVES AND ANALOGUES OXA1L, CYP51A1, CYP2C19 KDM4E 3561/4885HPGD 467/4885ALOX15 2603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.